mRNA

Assembly Line

Politics, Science and the Remarkable Race for a Coronavirus Vaccine

Date:

Authors: Sharon LaFraniere, Katie Thomas, Noah Weiland, David Gelles, Sheryl Gay Stolberg, Denise Grady

Topics: COVID-19, mRNA

Organizations: BioNTech, Moderna, Pfizer

The furious race to develop a coronavirus vaccine played out against a presidential election, between a pharmaceutical giant and a biotech upstart, with the stakes as high as they could get.

Read more at New York Times (Paid)

The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race

Date:

Author: @damiangarde

Topics: COVID-19, mRNA

Vertical: Pharmaceutical

Organizations: BioNTech, Moderna, Pfizer

The liquid that many hope could help end the Covid-19 pandemic is stored in a nondescript metal tank in a manufacturing complex owned by Pfizer, one of the world’s biggest drug companies. There is nothing remarkable about the container, which could fit in a walk-in closet, except that its contents could end up in the world’s first authorized Covid-19 vaccine.

Pfizer, a 171-year-old Fortune 500 powerhouse, has made a billion-dollar bet on that dream. So has a brash, young rival just 23 miles away in Cambridge, Mass. Moderna, a 10-year-old biotech company with billions in market valuation but no approved products, is racing forward with a vaccine of its own. Its new sprawling drug-making facility nearby is hiring workers at a fast clip in the hopes of making history — and a lot of money.

Read more at StatNews